Global investments into neglected disease R&D

The G-FINDER project has tracked and reported on global investments into neglected disease research and development (R&D) since 2008.

G-FINDER is a uniquely informative data source, providing policy-makers, donors, researchers and industry with objective, previously unavailable information on the state of investment, trends and patterns:

  • in 39 neglected diseasesIn financial year 2015 an investment of $3,041m invested in neglected disease R&D which was a reduction of 2.3% compared to previous years versus a $631m investment in Ebola and other African VHFs R&D for 2015 which was an increase of over 464 million USD or 288%
  • across 142 product areas for these diseases including drugs, vaccines, diagnostics, microbicides and vector control products and
  • in platform technologies (e.g. adjuvants, delivery technologies, diagnostic platforms)

The data includes all types of product-related R&D, including basic research, discovery and preclinical, clinical development, Phase IV and pharmacovigilance studies, and baseline epidemiological studies.

Funded by the Bill & Melinda Gates Foundation since inception, the G-FINDER project was originally hosted at The George Institute for International Health and then run by Policy Cures from 2010. Following the division of Policy Cures into two separate organisations in 2016, the G-FINDER project is now conducted by Policy Cures Research. Policy Cures Research is an independent, not-for-profit research think tank group established by the previous research and policy team from Policy Cures.


G-FINDER database (public search tool)

Image of public search tool and Policy Cures Research

The G-FINDER Public Search Tool provides open access to G-FINDER survey data that is not protected by confidentiality agreements. The Public Search Tool is updated annually and search results can be exported into Microsoft Excel for flexible data analysis.